Denver, CO, September 03, 2013 --(PR.com
)-- The 2013 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) keynote breakfast will include Kyle Lefkoff, founder and General Partner of Boulder Ventures, leading a conversation with the CEOs of Colorado's two premier publicly-traded pharmaceutical companies – Patrick Mahaffy, Founder and CEO of Clovis Oncology and Ron Squarer, CEO of Array BioPharma. The announcement is made by April Giles, President & CEO of the Colorado BioScience Association (CBSA) who says the regional conference will also feature a keynote luncheon presentation by Jeff Calcagno, M.D., Principal, Venture Investments, Johnson & Johnson Development Corporation.
Lefkoff, one of the region’s leading venture capitalists and a member of the conference steering committee since 2009, says: “Clovis Oncology and Array BioPharma have been incredibly successful reaching both funding and developmental milestones. This is a great opportunity to hear first-hand from their leadership how they have achieved this success and what they look forward to in the future.”
Regarding the conference as a whole Lefkoff says: “It’s important for us to showcase Colorado and other regional companies to investors from the rest of the country.”
Dr. Calcagno, RMLIPC luncheon keynote, joined Johnson & Johnson Development Corporation in 2013 after two years at the Johnson & Johnson Corporate Office of Science & Technology and the California Innovation Center. He has over two decades of healthcare and business experience: as a clinician, management consultant, research analyst, entrepreneur, and venture investor at Scale Venture Partners, a venture fund with over $1B under management.
About the Rocky Mountain Life Science Investor & Partnering Conference
The 2013 Rocky Mountain Life Science Investor & Partnering Conference – spearheaded by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah — will open with a reception at the Colorado Governor’s Mansion September 18th and follow with a full day of company pitch presentations September 19th at The Ritz-Carlton, Denver. Now in its 3rd biennial cycle, the RMLIPC is the region’s only investor conference for the life science industry. The conference will bring 30 of the region’s most innovative private and public life science companies together to present to a targeted audience of biotech, device, diagnostic and pharma investors and strategic partners. For more information and registration details, visit http://www.RockyMtnBioInvest.com
On Twitter, please use the hashtag #RockyMtnBioInvest for your tweets.
About Colorado BioScience Association
The CBSA is a not-for-profit organization providing services and support for Colorado's bioscience industry. With more than 350 members, CBSA actively works to promote the growth of the industry by advocating for a better business environment, growing the state's biotech workforce, fighting for policies that support a strong bioscience industry in the state, and speaking with a single voice on behalf of the industry. For more information, visit http://www.cobioscience.com
CBSA also is found on these social media sites:
LinkedIn Group: http://www.linkedin.com/groups?about=&gid=98468&trk=anet_ug_grppro
Facebook Fan Page: http://www.facebook.com/ColoradoBioScienceAssociation
News Feed: http://coloradobio.blogspot.com
YouTube Channel: http://www.youtube.com/COBioscience
Mae Desaire, Director of Marketing, Colorado BioScience Association - http://www.cobioscience.com – 720-382-5918, firstname.lastname@example.org
Maggie Chamberlin Holben, APR, Absolutely PR – http://www.absolutelypr.com – 303-984-9801, email@example.com